BiFinance (@BiFinanceE)

🚀 BiFinance will soon list HIVE/USDT! HIVE PROTOCOL is a next-generation AI-driven financial network, building the world’s first AI Finance core protocol by integrating AI computing power, on-chain finance, and traditional capital markets. 📌 Deposits: July 2, 08:30 UTC 📌 Trading: July 2, 08:30 UTC 📌 Withdrawals: July 2, 08:30 UTC 🌐 Official Website: #BiFinance# #HIVE# #AI# #AIFinance# #Web3# #RWA# #Crypto#

🚀 IPO Results Announced! The latest IPO allocation results are now live on BiFinance. 📌 Projects: 🔹 CREALIGHTS 🔹 CFMEE 🔹 SGMICRO Check your allocation now through the Messages Center or the IPO page in the BiFinance App. More exciting IPO opportunities are coming soon. Trade smarter with BiFinance. #BiFinance# #IPO# #Allocation# #InvestSmart# #HongKongIPO# #Stocks#

Anker Innovations IPO subscription is now open. A global smart hardware leader covering charging, energy storage, smart home, security, and audio solutions. Strong brand power, diversified products, and global reach create long-term growth potential. Offer Price: HKD 99.32 Deadline: June 26, 11:30 Watch the next tech growth opportunity in Hong Kong.

BiFinance has launched the Haiqing Zhiyuan /HKD trading pair. Details are as follows: Trading start time: June 24, 03:00 (UTC) Project Information: Shenzhen Haiqing Zhiyuan Technology Co., Ltd. was established in 2013 and is recognized by China's Ministry of Industry and Information Technology as a national-level specialized and innovative "Little Giant" enterprise. The company’s headquarters and R&D center are located in Shenzhen, China, with intelligent manufacturing centers in Shenzhen and Longyou, Zhejiang. According to the Frost & Sullivan research report, based on 2024 revenue, Haiqing Zhiyuan ranks first in market share among multispectral AI companies in China, ranks first nationwide in the multispectral AI large model service field, and ranks third nationwide in the multispectral AI module field. To date, the company has served over 2,500 customers worldwide. Official website:

🚀 #SPCX# Futures Now Live on BiFinance! 🔥 Up to 50x Leverage 📈 Capture market opportunities with flexible trading ⚡ Go long or short in any market condition Start trading now: #SPCX# #Futures# #BiFinance# #CryptoTrading# #LeverageTrading#

🚀 New Listing Alert #BiFinance# has officially launched Liuliumei/HKD! Liuliumei is a leading enterprise in China's fruit snack industry and a pioneer in plum products, committed to bringing consumers natural, healthy, and innovative snack experiences. 📈 Trading Pair: Liuliumei/HKD ⏰ Trading Started: June 18, 10:00 (UTC+8) Trade Hong Kong stocks and quality global assets on BiFinance. #Liuliumei# #HKStocks# #HongKongStocks# #BiFinance# #Trading#

#RWA# is transforming the way investors access global financial assets. #BiFinance# are excited to see innovators like @OndoFinance advancing the tokenization movement and bringing traditional assets closer to the on-chain economy. The future of finance may not be choosing between TradFi and Web3 — but connecting both worlds. #ONDO# #RWA# #Web3# #FutureOfFinance#

#BNB# continues to play an important role in the evolving Web3 ecosystem. What factor do you think will have the greatest impact on BNB's long-term growth? 🔹 Ecosystem Development 🔹 Real-World Adoption 🔹 On-Chain Innovation 🔹 User Growth Let us know your view below. 👇 #BNB# #Web3# #Crypto# #BiFinance#

The next generation doesn’t invest like the last one. Global access, mobile-first investing, and 24/7 markets are reshaping the future of stocks. #RWA# #StockToken# #Web3# #BiFinance#

🚀 BiFinance IPO Series | 龍豐集團 Hong Kong IPO 👉 龍豐集團 is a diversified enterprise with businesses covering building materials, property development and investment, and logistics. Backed by a solid financial foundation and extensive market experience, the Group continues creating long-term value. 🌍 Hong Kong IPO × Web3 📈 IPO Price: 6.38 HKD ⏰ Subscription Starts: 2026/5/28 9:00 Connecting traditional industries with global capital markets and unlocking new growth opportunities. #BiFinance# #IPO# #HongKongIPO# #Web3# #LungFungGroup#

🚀 BiFinance IPO Series | 天辰生物-B HK STOCK IPO 👉 As a biotechnology company focused on innovative drug development, 天辰生物-B is committed to creating globally best-in-class and first-in-class therapies for cancer and other serious diseases. 🧬 Biotech × HK Stock IPO 🌍 Bridging Traditional Finance and Web3 📈 IPO Price: 96.06 HKD ⏰ Subscription Starts: 2026/5/28 9:00 Innovation in biotechnology is accelerating toward global capital markets, reshaping the future of healthcare and finance. #BiFinance# #IPO# #HKStocks# #Biotech# #Web3#